129 related articles for article (PubMed ID: 3441450)
1. Effects of unilateral intracerebroventricular microinjections of cholecystokinin (CCK) on circling behavior of rats.
Morency MA; Ross GM; Hesketh D; Mishra RK
Peptides; 1987; 8(6):989-95. PubMed ID: 3441450
[TBL] [Abstract][Full Text] [Related]
2. Role of leptin in the control of feeding of goldfish Carassius auratus: interactions with cholecystokinin, neuropeptide Y and orexin A, and modulation by fasting.
Volkoff H; Eykelbosh AJ; Peter RE
Brain Res; 2003 May; 972(1-2):90-109. PubMed ID: 12711082
[TBL] [Abstract][Full Text] [Related]
3. Microinjection of cholecystokinin into the rat ventral tegmental area potentiates dopamine-induced hypolocomotion.
Crawley JN
Synapse; 1989; 3(4):346-55. PubMed ID: 2740993
[TBL] [Abstract][Full Text] [Related]
4. Rotational syndrome after central injection of C-terminal 7-peptide of cholecystokinin.
Mann JF; Boucher R; Schiller PW
Pharmacol Biochem Behav; 1980 Jul; 13(1):125-7. PubMed ID: 7190707
[TBL] [Abstract][Full Text] [Related]
5. Comparison of circling induced by unilateral intrastriatal microinjections of haloperidol, clozapine and CCK-8 in rats.
Weiss F; Ettenberg A
Pharmacol Biochem Behav; 1986 Apr; 24(4):983-9. PubMed ID: 3012602
[TBL] [Abstract][Full Text] [Related]
6. Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide.
Tanimoto K; Tamminga CA; Chase TN; Nilaver G
Endocrinology; 1987 Jul; 121(1):127-32. PubMed ID: 3297634
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence.
Crawley JN; Stivers JA; Blumstein LK; Paul SM
J Neurosci; 1985 Aug; 5(8):1972-83. PubMed ID: 4040554
[TBL] [Abstract][Full Text] [Related]
8. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
Katsuura G; Hsiao S; Itoh S
Peptides; 1984; 5(3):529-34. PubMed ID: 6089145
[TBL] [Abstract][Full Text] [Related]
9. Similar potencies of CCK-8 and its analogue BOC(Nle28;Nle31)CCK27-33 on the self-stimulation behaviour both are antagonized by a newly synthesized cyclic CCK analogue.
Heidbreder C; Roques BP; De Witte P
Neuropeptides; 1989; 13(2):89-94. PubMed ID: 2739884
[TBL] [Abstract][Full Text] [Related]
10. A behavioural pharmacological study on intracerebroventricularly administered CCK-8 related peptides in mice.
Hagino Y; Moroji T; Iizuka R
Neuropeptides; 1989; 13(2):107-13. PubMed ID: 2739882
[TBL] [Abstract][Full Text] [Related]
11. Preventive effect of cholecystokinin octapeptide on experimental amnesia in rats.
Katsuura G; Itoh S
Peptides; 1986; 7(1):105-10. PubMed ID: 3714527
[TBL] [Abstract][Full Text] [Related]
12. Influence of cholecystokinin on central monoaminergic pathways.
Widerlöv E; Kalivas PW; Lewis MH; Prange AJ; Breese GR
Regul Pept; 1983 May; 6(2):99-109. PubMed ID: 6308717
[TBL] [Abstract][Full Text] [Related]
13. Effects of amylin on feeding of goldfish: interactions with CCK.
Thavanathan R; Volkoff H
Regul Pept; 2006 Jan; 133(1-3):90-6. PubMed ID: 16239037
[TBL] [Abstract][Full Text] [Related]
14. Balance of glutamate and dopamine in the nucleus accumbens modulates self-stimulation behavior after injection of cholecystokinin and neurotensin in the rat brain.
Heidbreder C; Gewiss M; De Mot B; Mertens I; De Witte P
Peptides; 1992; 13(3):441-9. PubMed ID: 1523160
[TBL] [Abstract][Full Text] [Related]
15. Effects induced by BC 264, a selective agonist of CCK-B receptors, on morphine-dependent rats.
Maldonado R; Valverde O; Derrien M; Tejedor-Real P; Roques BP
Pharmacol Biochem Behav; 1994 Jun; 48(2):363-9. PubMed ID: 8090802
[TBL] [Abstract][Full Text] [Related]
16. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
[TBL] [Abstract][Full Text] [Related]
17. Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide.
Kádár T; Fekete M; Telegdy G
Acta Physiol Acad Sci Hung; 1981; 58(4):269-74. PubMed ID: 6291322
[TBL] [Abstract][Full Text] [Related]
18. Evidence for dopaminomimetic effect of intrastriatally injected cholecystokinin octapeptide in mice.
Worms P; Martinez J; Briet C; Castro B; Biziere K
Eur J Pharmacol; 1986 Mar; 121(3):395-401. PubMed ID: 3699101
[TBL] [Abstract][Full Text] [Related]
19. Opposite actions of CCK-8 on amphetamine-induced hyperlocomotion and stereotypy following intracerebroventricular and intra-accumbens injections in rats.
Weiss F; Tanzer DJ; Ettenberg A
Pharmacol Biochem Behav; 1988 Jun; 30(2):309-17. PubMed ID: 3174761
[TBL] [Abstract][Full Text] [Related]
20. The behavioral effects of CCK8 injected into the medial nucleus accumbens are dependent on the motivational state of the rat.
Daugé V; Dor A; Féger J; Roques BP
Eur J Pharmacol; 1989 Apr; 163(1):25-32. PubMed ID: 2744093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
